In this downloadable slideset, Dafna D. Gladman, MD, FRCPC, reviews the role of IL-17A in psoriatic arthritis and examines key data surrounding the use of IL-17–targeted therapies to treat this condition.
In this interactive, CME-certified video module, Dafna D. Gladman, MD, FRCPC, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.
The 2016 American College of Rheumatology annual meeting gave us promising data on agents targeting IL-17 in psoriatic arthritis. Here’s my take on select abstracts.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.